Mitra Ramgopal
Stock Analyst at Sidoti & Co.
(3.07)
# 1,302
Out of 4,786 analysts
21
Total ratings
73.33%
Success rate
33.14%
Average return
Main Sectors:
Stocks Rated by Mitra Ramgopal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BCPC Balchem | Upgrades: Buy | $175 | $166.00 | +5.42% | 6 | Feb 22, 2022 | |
| TRNS Transcat | Upgrades: Buy | $60 | $74.45 | -19.41% | 2 | May 19, 2021 | |
| AMN AMN Healthcare Services | Maintains: Buy | $72 → $70 | $24.46 | +186.18% | 5 | Jun 16, 2020 | |
| ADUS Addus HomeCare | Maintains: Buy | $96 → $115 | $98.89 | +16.29% | 4 | Jun 1, 2020 | |
| USPH U.S. Physical Therapy | Maintains: Buy | $128 → $80 | $72.36 | +10.56% | 1 | Mar 27, 2020 | |
| BEAT HeartBeam | Maintains: Buy | $81 → $75 | $2.01 | +3,631.34% | 3 | Feb 27, 2020 |
Balchem
Feb 22, 2022
Upgrades: Buy
Price Target: $175
Current: $166.00
Upside: +5.42%
Transcat
May 19, 2021
Upgrades: Buy
Price Target: $60
Current: $74.45
Upside: -19.41%
AMN Healthcare Services
Jun 16, 2020
Maintains: Buy
Price Target: $72 → $70
Current: $24.46
Upside: +186.18%
Addus HomeCare
Jun 1, 2020
Maintains: Buy
Price Target: $96 → $115
Current: $98.89
Upside: +16.29%
U.S. Physical Therapy
Mar 27, 2020
Maintains: Buy
Price Target: $128 → $80
Current: $72.36
Upside: +10.56%
HeartBeam
Feb 27, 2020
Maintains: Buy
Price Target: $81 → $75
Current: $2.01
Upside: +3,631.34%